LOINC Code 73967-2: Noninvasive prenatal fetal aneuploidy panel (cfDNA)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Noninvasive prenatal fetal aneuploidy panel. It is commonly used with the system or sample type Plas.cfDNA.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Order
• Panel type: Panel

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA
• Noninvasive prenatal fetal aneuploidy panel
• Noninvasive prenatal testing for risk of fetal aneuploidy (e.g. trisomy 21, XXY, etc.) is performed using maternal plasma (or serum) which contains circulating cell free (ccf) DNA from the fetus. The probability and result interpretation (high risk/low risk) of aneuploidy are based on dosage ccf DNA from the mother and fetus as well as the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of trisomy 13, 18 and 21 as well as fetal sex chromosome aneuploidy in women with singleton pregnancies of at least 10 weeks gestational age.
• Molecular pathology; MOLPATH; NIP fet aneu Pnl; NIPS; Non-invasive prenatal screening; Noninvasive prenatal testing; NPT; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions